3rd Quarter - Termination
COVE STRATEGIES for RETROPHIN, INC.
Firm
Client
Income
$20,000
Expenses
—
Terminated
Jul 25, 2020
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
S. 340 - CREATES Act of 2019, The Orphan Drug Act, Drug Pricing, Advancing American Kidney Initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA FLOOD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.